Coal tar with calamine
A topical preparation combining coal tar with calamine, used for chronic inflammatory and scaling skin conditions such as psoriasis and eczema, where the calamine provides a soothing, mildly astringent effect alongside the antiscaling action of tar.
ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.
Clinical monograph
How it works
Coal tar provides anti-inflammatory, antimitotic, antiscaling and antipruritic effects on the skin, while calamine (a zinc oxide-based preparation) acts as a soothing protectant that relieves itching and mild irritation.
Prescribing in practice
- As with all coal tar products it increases photosensitivity, so treated skin should be protected from sunlight and caution applied if phototherapy is used.
- Avoid application to broken, infected or acutely inflamed skin, where tar can cause irritation or folliculitis.
- The preparation stains skin, hair, clothing and bedding and has a tar odour.
Monitoring
No laboratory monitoring is required; review the skin clinically for irritation and response.
Counselling the patient
- Apply as directed; expect staining of fabrics and a characteristic smell.
- Keep treated skin out of strong sunlight.
- Stop if the skin becomes irritated or spotty and seek advice.
Evidence & guidelines
Coal tar-containing topical preparations are an established adjunct in chronic plaque psoriasis and eczema, used within stepped topical regimens recommended by NICE.
Reference: Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).
Related
Curated clinical cross-links plus same-class fallbacks.
- PASI — Psoriasis Area and Severity Index · Diagnosis
- DLQI — Dermatology Life Quality Index · Diagnosis
- PASI Score (Psoriasis Area and Severity Index) · Psoriasis
- DLQI (Dermatology Life Quality Index) · Quality of Life
- FAST Exam Protocol — Focused Assessment with Sonography in Trauma · Trauma
- CASPAR Criteria for Psoriatic Arthritis · Diagnosis
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD